Q32 Bio (QTTB) Non Operating Income (2023 - 2026)

Q32 Bio's Non Operating Income history runs 4 years deep, the most recent figure standing at $113000.0 for Q1 2026.

• On a quarterly basis, Non Operating Income fell 90.56% year-over-year to $113000.0 in Q1 2026; TTM through Mar 2026 was $11.8 million, a 129.16% increase from a year earlier, with the FY2025 full-year figure at $12.9 million, down 35.45% from the prior year.
• Non Operating Income slipped to $113000.0 in Q1 2026 per QTTB's latest filing, from $11.9 million in the prior quarter.
• Across five years, Non Operating Income topped out at $16.0 million in Q1 2024 and bottomed at -$6.2 million in Q3 2023.
• The 4-year median for Non Operating Income is $535000.0 (2023), against an average of $2.1 million.
• Biggest YoY gain for Non Operating Income was 3210.34% in 2025; the steepest drop was 113.31% in 2025.
• Year by year, Non Operating Income stood at -$1.0 million in 2023, then soared by 135.62% to $358000.0 in 2024, then soared by 3210.34% to $11.9 million in 2025, then plunged by 99.05% to $113000.0 in 2026.
• Per Business Quant, the three latest QTTB Non Operating Income figures stand at $113000.0 (Q1 2026), $11.9 million (Q4 2025), and $188000.0 (Q3 2025).